心臓　55/10　2023年10月号

出版社： 日本医学出版
発行日： 2023-10-15
分野： 臨床医学：内科  >  雑誌
ISSN： 05864488
雑誌名：
電子書籍版： 2023-10-15
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,200 円(税込)

購入する

目次

  • Open HEART
    さあ，これからどうする「腫瘍循環器」

    HEART’s Selection
    重症心不全治療の現在地　心臓移植、補助循環デバイス
    1． 重症心不全治療の対象となる患者の変遷
    2． 体外設置型VADおよびCentral ECMO治療の現在地
    3． 植込型VAD治療の変遷
    4． 小児のVAD治療について
    5． 心臓外科領域におけるImpellaの適用と応用
    6． 本邦未導入のタイプも含めたImpella治療（外科の視点から）
    7． Impella治療（内科・集中治療科の視点から）

    [連載]HEART's　Column
    Authorが語る日本発のクリニカル・エビデンス：論文の解説と発表後の展望
    Histological validation of atrial structural remodelling in patients with
    　atrial fibrillation
    心房細動患者における心房構造的リモデリングの組織学的検証

    [連載]HEART’s Up To Date
    循環器医が知っておくべき最新のエビデンス

    HEART’s Original
    [総説]
    慢性期・維持期冠動脈疾患に対する心臓リハビリテーションの有効性に関するレビュー
    [臨床研究]
    心血管検診における血漿BNP高値の関連因子と性差
    [Editorial Comment]
    須川論文に対するEditorial　Comment
    [症例]
    開腹再手術を行ったEVAR術後エンドテンションの１例
    [症例]
    左房壁に発生した可動性乳頭状弾性線維腫の1手術例
    [症例]
    急性下肢動脈閉塞に対し経カテーテル的にFogartyカテーテルを用いて血栓除去術を行った1例

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【HEART' s Selection】

P.963 掲載の参考文献
1) McDonagh TA, Metra M, Adamo M, et al : 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021 ; 42 : 3599-3726
 
2) Heidenreich PA, Bozkurt B, Aguilar D, et al : 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure : A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022 ; 145 : e895-e1032
 
3) 日本循環器学会 : 循環器病ガイドラインシリーズ 2016年版 : 2016年版心臓移植に関する提言. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2016_isobe_h.pdf (cited 2023 Aug 15)
 
4) 補助人工心臓治療関連学会協議会 : 植込型補助人工心臓DT実施基準 (2023.8.7 改定). https://j-vad.jp/document/%E6%A4%8D%E8%BE%BC%E5%9E%8B%E8%A3%9C%E5%8A%A9%E4%BA%BA%E5%B7%A5%E5%BF%83%E8%87%9FDT%E5%AE%9F%E6%96%BD%E5%9F%BA%E6%BA%9620230807%E6%94%B9%E5%AE%9A.pdf?ver=20230808C (cited 2023 Aug 15)
 
5) Stevenson LW, Pagani FD, Young JB, et al : INTERMACS profiles of advanced heart failure : the current picture. J Heart Lung Transplant 2009 ; 28 : 535-541
 
6) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会 : 2021年改訂版 重症心不全に対する植込型補助人工心臓治療ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Ono_Yamaguchi.pdf (cited 2023 Aug 15)
 
7) Molina EJ, Shah P, Kiernan MS, et al : The Society of Thoracic Surgeons Intermacs 2020 Annual Report. Ann Thorac Surg 2021 ; 111 : 778-792
 
8) Kinugawa K, Nishimura T, Toda K, et al : The second official report from Japanese registry for mechanical assisted circulatory supporr (J-MACS) : first results of bridge to bridge strategy. Gen Thorac Cardiovasc Surg 2020 ; 68 : 102-111
 
9) 日本心臓移植研究会 : 心臓移植レジストリ報告. http://www.jsht.jp/%E3%83%AC%E3%82%B8%E3%82%B9%E3%83%88%E3%83%AA20221231.pdf (cited 2023 Aug 15)
 
10) Rose EA, Gelijns AC, Moskowitz AJ, et al : Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001 ; 345 : 1435-1443
 
P.968 掲載の参考文献
1) Fukushima S, Tadokoro N, Koga A, et al : Central conversion from peripheral extracorporeal life support for patients with refractory congestive heart failure. J Artif Organs 2020 ; 23 : 214-224
 
2) Tadokoro N, Fukushima S, Minami K, et al : Efficacy of central extracorporeal life support for patients with fulminant myocarditis and cardiogenic shock. Eur J Cardiothorac Surg 2021 ; 60 : 1184-1192
 
3) Bonicolini E, Martucci G, Simons J, et al : Limb ischemia in peripheral veno-arterial extracorporeal membrane oxygenation : a narrative review of incidence, prevention, monitoring, and treatment. Crit Care 2019 ; 23 : 266
PubMed
4) Ruszel N, Kielbowski K, Piotrowska M, et al : Central, peripheral ECMO or CPB? Comparsion between circulatory support methods used during lung transplantation. J Cardiothorac Surg 2021 ; 16 : 341
PubMed
5) Raffa GM, Kowalewski M, Brodie D, et al : Meta-Analysis of Peripheral or Central Extracorporeal Membrane Oxygenation in Postcardiotomy and Non-Postcardiotomy Shock. Ann Thorac Surg 2019 ; 107 : 311-321
PubMed
6) Tonai K, Fukushima S, Tadokoro N, et al : Bridge from central extracorporeal life support is a risk factor of cerebrovascular accidents after durable left ventricular assist device implantation. J Artif Organs 2022 ; 25 : 214-222
 
7) Inoue K, Fujita T, Yoshioka D, et al : Short-Term Outcomes of Magnetically Levitated Left Ventricular Assist Device in Advanced Heart Failure - The Japanese Cohort. Circ J 2022 ; 86 : 1961-1967
 
P.975 掲載の参考文献
1) J-MACS委員会 : 日本における補助人工心臓に関連した市販後のデータ収集. https://www.jpats.org/lib/files/society/jmacs/statistical_report_201006-202112.pdf (cited 2023 Aug 10)
 
2) 日本心臓移植研究会 : 心臓移植レジストリ報告. http://www.jsht.jp/registry/japan/%E5%BF%83%E8%87%93%E7%A7%BB%E6%A4%8D%E3%80%8020220831.pdf (cited 2023 Aug 10)
 
3) Omoto R, Kyo S, Nishimura M, et al : Japanese multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system. J Artif Organs 2005 ; 8 : 34-40
 
4) Matsuda H, Fukushima N, Sawa Y, et al : First brain dead donor heart transplantation under new legislation in Japan. Jpn J Thorac Cardiovasc Surg 1999 ; 47 : 499-505
 
5) 許俊鋭 : 補助人工心臓の臨床導入から植込型LVADによるDestination Therapy (DT) 導入までの軌跡. 循環器専門医 2022 ; 31 : 127-131
 
6) Najjar SS, Slaughter MS, Pagani FD, et al : An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 2014 ; 33 : 23-34
 
7) Starling RC, Moazami N, Silvestry SC, et al : Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014 ; 370 : 33-40
PubMed
8) Mehra MR, Uriel N, Naka Y, et al : A Fully Magnetically Levitated Left Ventricular Assist Device-Final Report. N Engl J Med 2019 ; 380 : 1618-1627
 
9) Miller LW, Pagani FD, Russell SD, et al : Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007 ; 357 : 885-896
 
10) Slaughter MS, Rogers JG, Milano CA, et al : Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009 ; 361 : 2241-2251
 
11) Ono M, Sawa Y, Nakatani T, et al : Japanese Multicenter Outcomes With the HeartMate II Left Ventricular Assist Device in Patients With Small Body Surface Area. Circ J 2016 ; 80 : 1931-1936
PubMed
12) Klovaite J, Gustafsson F, Mortensen SA, et al : Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol 2009 ; 53 : 2162-2167
 
13) Ichihara Y, Nishinaka T, Komagamine M, et al : Preservation of von Willebrand factor multimers and function in patients with an EVAHEART centrifugal-type, continuous-flow left ventricular assist device. J Heart Lung Transplant 2017 ; 36 : 814-817
 
14) Saito S, Yamazaki K, Nishinaka T, et al : Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART : a Japanese multicenter study using J-MACS. J Heart Lung Transplant 2014 ; 33 : 599-608
 
15) Motomura T, Kelly B : Surgical Techniques for Implanting the EVAHEART 2 Double Cuff Tipless Inflow Cannula. ASAIO J 2019 ; 65 : e86-e89
 
16) Ushijima T, Tanoue Y, Sonoda H, et al : Potential of the EVAHEART 2 Double-Cuff Tipless Inflow Cannula for Prevention of Thromboembolic Events. ASAIO J 2022 ; 68 : e168-e171
 
17) Aaronson KD, Slaughter MS, Miller LW, et al : Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012 ; 125 : 3191-3200
 
18) Rogers JG, Pagani FD, Tatooles AJ, et al : Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure. N Engl J Med 2017 ; 376 : 451-460
 
19) Pagani FD, Cantor R, Cowger J, et al : Concordance of Treatment Effect : An Analysis of The Society of Thoracic Surgeons Intermacs Database. Ann Thorac Surg 2022 ; 113 : 1172-1182
 
20) Potapov EV, Nersesian G, Lewin D, et al : Propensity score-based analysis of long-term follow-up in patients supported with durable centrifugal left ventricular assist devices : the EUROMACS analysis. Eur J Cardiothorac Surg 2021 ; 60 : 579-587
 
P.981 掲載の参考文献
1) Stewart GC, Mehra MR : A history of devices as an alternative to heart transplantation. Heart Fail Clin 2014 ; 10 : S1-12
 
2) Almond CS, Morales DL, Blackstone EH, et al : Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation 2013 ; 127 : 1702-1711
 
3) Mehra M, Uriel N, Naka Y, et al : A Fully Magnetically Levitated Left Ventricular Assist Device-Final Report. N Engl J Med 2019 ; 380 : 1618-1627
 
4) Rossano JW, Lorts A, VanderPluym CJ, et al : Out-comes of pediatric patients supported with continuous-flow ventricular assist devices : A report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant 2016 ; 35 : 585-590
 
5) J-MACS Statistical Report 最新版 : https://www.jpats.org/lib/files/society/jmacs/statistical_report_201006-202112.pdf (cited 2023 Jun 25)
 
P.984 掲載の参考文献
1) Rastan A, Dege A, Mohr M, et al : Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010 ; 139 : 302-311
 
2) Fux T, Holm M, Corbascio M, et al : Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock : Risk factors for mortality. J Thorac Cardiovasc Surg 2018 ; 156 : 1894-1902
 
3) David CH, Quessard A, Mastroianni C, et al : Mechanical circulatory support with the Impella 5.0 and the Impella Left Direct pumps for postcardiotomy cardiogenic shock at La Pitie-Salpetriere Hospital. Eur J Cardiothorac Surg 2020 ; 57 : 183-188
 
4) Saito S, Shibasaki I, Matsuoka T, et al : Impella support as a bridge to heart surgery in patients with cardiogenic shock. Interact Cardiovasc Thorac Surg 2022 ; 35 : ivac088
PubMed
5) Benke K, Korca E, Boltjes A, et al : Preventive Impella(R) Support in High-Risk Patients Undergoing Cardiac Surgery. J Clin Med 2022 ; 11 : 5404
PubMed
6) 森佳織, 郷田素彦, 澁谷泰介, ほか : IMPELLA 5.0(R) によるbridge to surgeryで救命し得た急性僧帽弁閉鎖不全症の1例. 日本心臓血管外科学会雑誌 2019 ; 48 : 392-395
 
7) Cevasco M, Shin M, Cohen W, et al : Impella 5.5 as a bridge to heart transplantation : Waitlist outcomes in the United States. Clin Transplant 2023 Jul 1 ; e15066
PubMed
8) 時事メディカル : 補助循環用ポンプカテーテルのメリットとは. 2023/05/22. https://medical.jiji.com/news/56857 (cited 2023 Aug 15)
 
P.990 掲載の参考文献
1) Thiele H, Zeymer U, Neumann FJ, et al : Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012 ; 367 : 1287-1296
 
2) Goldberg RJ, Makam RCP, Yarzebski J, et al : Decade-Long Trends (2001-2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2016 ; 9 : 117-125
 
3) van Diepen S, Katz JN, Albert NM, et al : Contemporary management of cardiogenic shock : a scientific statement from the American Heart Association. Circulation 2017 ; 136 : e232-268
 
4) Kolte D, Khera S, Aronow WS, et al : Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc 2014 ; 3 : e000590
PubMed
5) Iannaccone M, Franchin L, Hanson ID, et al : Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock : an updated meta-analysis. Int J Cardiol 2022 ; 362 : 47-54
 
6) Basir MB, Schreiber TL, Grines CL, et al : Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock. Am J Cardiol 2017 ; 119 : 845-851
 
7) Ouweneel DM, Eriksen E, Sjauw KD, et al : Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2017 ; 69 : 278-287
 
8) Fincke R, Hochman JS, Lowe AM, et al : Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock : a report from the SHOCK trial registry. J Am Coll Cardiol 2004 ; 44 : 340-348
 
9) O'Neill WW, Kleiman NS, Moses J, et al : A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention : the PROTECT II study. Circulation 2012 ; 126 : 1717-1727
 
10) Basir MB, Schreiber T, Dixon S, et al : Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock : The Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv 2018 ; 91 : 454-461
 
11) Zaky M, Nordan T, Kapur NK, et al : Impella 5.5 Support Beyond 50 Days as Bridge to Heart transplant in End-Stage Heart Failure Patients. ASAIO J 2023 ; 69 : e158-e162
 
12) Funamoto M, Kunavarapu C, Kwan M, et al : Single center experience and early outcome of Impella 5.5. Front Cardiovasc Med 2023 ; 10 : 1018203
PubMed
13) Biancari F, Dalen M, Fiore A, et al : Multicenter study on postcardiotomy venoarterial extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 2020 ; 159 : 1844-1854.e6
 
14) Ge M, Pan T, Wang JX, et al : Outcomes of early versus delayed initiation of extracorpeal life support in cardiac surgery. J Cardiothorac Surg 2019 ; 14 : 129
 
P.994 掲載の参考文献
1) 補助人工心臓治療関連学会協議会インペラ部会 : 適正使用指針. http://j-pvad.jp/guidance/ (cited 2023 Aug 30)
 
2) 日本循環器学会/日本心臓血管外科学会/日本心臓病学会/日本心血管インターベンション治療学会 : 2023年JCS/JSCVS/JCC/CVIT ガイドラインフォーカスアップデート版 PCPS/ECMO/循環補助用心内留置型ポンプカテーテルの適応・操作. https://www.j-circ.or.jp/cms/wp-content/uploads/2023/03/JCS2023_nishimura.pdf (cited 2023 Aug 30)
 
3) Baran DA, Grines CL, Bailey S, et al : SCAI clinical expert consensus statement on the classification of cardiogenic shock : This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 2019 ; 94 : 29-37
 
4) Kapur NK, Qiao X, Paruchuri V, et al : Mechanical Pre-Conditioning With Acute Circulatory Support Before Reperfusion Limits Infatct Size in Acute Myocardial Infarction. JACC Heart Fail 2015 ; 3 : 873-882
 
5) Saku K, Kakino T, Arimura T, et al : Left Ventricular Mechanical Unloading by Total Support of Impella in Myocardial Infarction Reduces Infarct Size, Preserves Left Ventricular Function, and Prevents Subsequent Heart Failure in Dogs. Circ Heart Fail 2018 ; 11 : e004397
PubMed
6) Swain L, Reylet L, Bhave S, et al : Transvalvular Ventricular Unloading Before Reperfusion in Acute Myocardial Infarction. J Am Coll Cardiol 2020 ; 76 : 684-699
 
7) Flaherty MP, Khan AR, O'Neill WW : Early Initiation of Impella in Acute Myocardial Infarction Complicated by Cardiogenic Shock Improves Survival : A Meta-Analysis. JACC Cardiovasc Interv 2017 ; 10 : 1805-1806
 
8) Sakamoto T, Morimura N, Nagao K, et al : Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest : a prospective observational study. Resuscitation 2014 ; 85 : 762-768
 
9) Schrage B, Burkhoff D, Rubsamen N, et al : Unloading of the Left Ventricle During Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock. JACC Heart Fail 2018 ; 6 : 1035-1043
 
10) Tschope C, Van Linthout S, Klein O, et al : Mechanical Unloading by Fulminant Myocardits : LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts. J Cardiovasc Transl Res 2019 ; 12 : 116-123
 

【連載】

P.998 掲載の参考文献
1) Yamaguchi T, Tsuchiya T, Nakahara S, et al : Efficacy of Left Atrial Voltage-based Catheter Ablation of Persistent Atrial Fibrillation. J Cardiovasc Electrophysiol 2016 ; 27 : 1055-1063
 
2) Yamaguchi T, Otsubo T, Takahashi Y, et al : Atrial Structural Remodeling in Patients With Atrial Fibrillation Is a Diffuse Fibrotic Process : E vidence From High-Density Voltage Mapping and Atrial Biopsy. J Am Heart Assoc 2022 ; 11 : e024521
 
3) Takahashi Y, Yamaguchi T, Otsubo T, Nakashima K, Shinzato K, Osako R, Shichida S, Kawano Y, Fukui A, Kawaguchi A, Aishima S, Saito T, Takahashi N, Node K : Histological validation of atrial structural remodelling in patients with atrial fibrillation. Eur Heart J 202 Jun 23 ; ehad396. doi : 10.1093/eurheartj/ehad396. [Online ahead of print]
 
P.1001 掲載の参考文献
1) McDonagh TA, Metra M, Adamo M, et al : 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021 ; 42 : 3599-3726
 
2) Anker SD, Butler J, Filippatos G, et al : Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med 2021 ; 385 : 1451-1461
 
3) Solomon SD, McMurray JJV, Claggett B, et al : Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med 2022 ; 387 : 1089-1098
 
4) Mebazaa A, Davison B, Chioncel O, et al : Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF) : a multinational, open-label, randomised, trial. Lancet 2022 ; 400 : 1938-1952
 
5) Heerspink HJL, Stefansson BV, Correa-Rotter R, et al : Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 2020 ; 383 : 1436-1446
 
6) Herrington WG, Staplin N, Wanner C, et al : Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 2023 ; 388 : 117-127
 
7) Bakris GL, Agarwal R, Anker SD, et al : Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 2020 ; 383 : 2219-2229
 
8) Pitt B, Filippatos G, Agarwal R, et al : Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. N Engl J Med 2021 ; 385 : 2252-2263
 
9) Kalra PR, Cleland JGF, Petrie MC, et al : Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN) : an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet 2022 ; 400 : 2199-2209
 
10) Ponikowski P, Kirwan BA, Anker SD, et al : Ferric carboxymaltose for iron deficiency at discharge after acute heart failure : a multicentre, double-blind, randomised, controlled trial. Lancet 2020 ; 396 : 1895-1904
 

【HEART' s Original】

P.1013 掲載の参考文献
1) 厚生労働省 : 令和2年 (2020) 人口動態統計 (確定数) の概況. 死因簡単分類別にみた性別死亡数・死亡率 (人口10万対). https://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei20/dl/11_h7.pdf (cited 2022 Dec 4)
 
2) Makita S, Yasu T, Akashi YJ, et al : JCS/JACR 2021 Guideline on Rehabilitation in Patients With Cardiovascular Disease. Circ J 2022 ; 87 : 155-235
 
3) Kanaoka K, Soeda T, Terasaki S, et al : Current Status and Effect of Outpatient Cardiac Rehabilitation After Percutaneous Coronary Intervention in Japan. Circ Rep 2021 ; 3 : 122-130
 
4) Ogura A, Izawa KP, Tawa H, et al : Impact of the COVID-19 pandemic on phase 2 cardiac rehabilitation patients in Japan. Heart Vessels 2021 ; 36 : 1184-1189
 
5) Froelicher V, Jenson D, Genter F, et al : A randomized trial of exercise training in patients with coronary heart disease. JAMA 1984 ; 252 : 1291-1297
 
6) Niebauer J, Hambrecht R, Velich T, et al : Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention. Circulation 1997 ; 96 : 2534-2541
 
7) Long L, Anderson L, Dewhirst AM, et al : Exercise-based cardiac rehabilitation for adults with stable angina. Cochrane Database Syst Rev 2018 ; 2 : CD012786
PubMed
8) Dibben G, Faulkner J, Oldridge N, et al : Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2021 ; 11 : CD001800
PubMed
9) Dibben GO, Faulkner J, Oldridge N, et al : Exercise-based cardiac rehabilitation for coronary heart disease : a meta-analysis. Eur Heart J 2023 ; 44 : 452-469
 
10) Saito M, Ueshima K, Saito M, et al ; Japanese Cardiac Rehabilitation Survey Investigators. Safety of exercise-based cardiac rehabilitation and exercise testing for cardiac patients in Japan : a nationwide survey. Circ J 2014 ; 78 : 1646-1653
 
11) Sterne JAC, Savovic J, Page MJ, et al : RoB 2 : a revised tool for assessing risk of bias in randomised trials. BMJ 2019 ; 366 : l4898
PubMed
12) Wilhelmsen L, Sanne H, Elmfeldt D, et al : A controlled trial of physical training after myocardial infarction. Effects on risk factors, nonfatal reinfarction, and death. Prev Med 1975 ; 4 : 491-508
 
13) Roman O, Gutierrez M, Luksic I, et al : Cardiac rehabilitation after acute myocardial infarction. 9-year controlled follow-up study. Cardiology 1983 ; 70 : 223-231
 
14) Ornish D, Brown SE, Scherwitz LW, et al : Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990 ; 336 : 129-133
 
15) Haskell WL, Alderman EL, Fair JM, et al : Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994 ; 89 : 975-990
 
16) Dugmore LD, Tipson RJ, Phillips MH, et al : Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme. Heart 1999 ; 81 : 359-366
 
17) Higgins HC, Hayes RL, McKenna KT : Rehabilitation outcomes following percutaneous coronary interventions (PCI). Patient Educ Couns 2001 ; 43 : 219-230
 
18) Vestfold Heartcare Study Group : Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 2003 ; 10 : 429-437
 
19) Seki E, Watanabe Y, Shimada K, et al : Effects of a phase III cardiac rehabilitation program on physical status and lipid profiles in elderly patients with coronary artery disease : Juntendo Cardiac Rehabilitation Program (J-CARP). Circ J 2008 ; 72 : 1230-1234
 
20) Houle J, Doyon O, Vadeboncoeur N, et al : Effectiveness of a pedometer-based program using a socio-cognitive intervention on physical activity and quality of life in a setting of cardiac rehabilitation. Can J Cardiol 2012 ; 28 : 27-32
 
21) Byrkjeland R, Njerve IU, Anderssen S, et al : Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease : A randomised clinical trial. Diab Vasc Dis Res 2015 ; 12 : 325-333
 
22) Hautala AJ, Kiviniemi AM, Makikallio T, et al : Economic evaluation of exercise-based cardiac rehabilitation in patients with a recent acute coronary syndrome. Scand J Med Sci Sports 2017 ; 27 : 1395-1403
 
23) He CJ, Zhu CY, Zhu YJ, et al : Effect of exercise-based cardiac rehabilitation on clinical outcomes in patients with myocardial infarction in the absence of obstructive coronary artery disease (MINOCA). Int J Cardiol 2020 ; 315 : 9-14
 
24) Uddin J, Joshi VL, Moniruzzaman M, et al : Effect of Home-Based Cardiac Rehabilitation in a Lower-Middle Income Country : RESULTS FROM A CONTROLLED TRIAL. J Cardiopulm Rehabil Prev 2020 ; 40 : 29-34
 
25) Lunde P, Bye A, Bergland A, et al : Long-term follow-up with a smartphone application improves exercise capacity post cardiac rehabilitation : A randomized controlled trial. Eur J Prev Cardiol 2020 ; 27 : 1782-1792
 
26) Xiao M, Li Y, Guan X : Community-Based Physical Rehabilitation After Percutaneous Coronary Intervention for Acute Myocardial Infarction. Tex Heart Inst J 2021 ; 48 : e197103
 
27) Dalli Peydro E, Sanz Sevilla N, Tuzon Segarra MT, et al : A randomized controlled clinical trial of cardiac telerehabilitation with a prolonged mobile care monitoring strategy after an acute coronary syndrome. Clin Cardiol 2022 ; 45 : 31-41
 
28) Kaihara T, Intan-Goey V, Scherrenberg M, et al : Impact of activity trackers on secondary prevention in patients with coronary artery disease : a systematic review and meta-analysis. Eur J Prev Cardiol 2022 ; 29 : 1047-1056
 
P.1022 掲載の参考文献
1) Yasue H, Yoshimura M, Sumida H, et al : Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994 ; 90 : 195-203
 
2) 日本循環器学会/日本心不全学会 : 急性・慢性心不全診療ガイドライン (2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h.pdf (cited 2022 Jul 10)
 
3) Kawai M, Yoshimura M, Harada M, et al : Determination of the B-type Natriuretic Peptide Level as a Criterion for Abnormalities in Japanese Individuals in Routine Clinical Practice : The J-ABS Multi-center Study (Japan Abnormal BNP Standard). Intern Med 2013 ; 52 : 171-177
 
4) Lang RM, Badano LP, Mor-Avi V, et al : Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015 ; 28 : 1-39
 
5) Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al : Plasma brain natriuretic peptide concentration : impact of age and gender. J Am Coll Cardiol 2002 ; 40 : 976-982
 
6) Lam CSP, Cheng S, Choong K, et al : Influence of Sex and Hormone Status on Circulating Natriuetic Peptides. J Am Coll Cardiol 2011 ; 58 : 618-626
 
7) Choi HI, Lee MY, Oh BK, et al : Effect of Age, Sex, and Obesity on N-Terminal Pro B-Type Natriuretic Peptide Concentrations in the General Population. Circ J 2021 ; 85 : 647-654
 
8) Tsang TS, Barnes ME, Gersh BJ, et al : Left Atrial Volume as a Morphophysiologic Expression of Left Ventricular Diastolic Dysfunction and Relation to Cardiovascular Risk Burden. Am J Cardiol 2002 ; 90 : 1284-1289
 
9) Fukuta H, Ohte N, Mukai S, et al : Anemia is an Independent Predictor for Elevated Plasma Levels of Natriuretic Peptides in Patients Undergoing Cardiac Catheterization for Coronary Artery Disease. Circ J 2008 ; 72 : 212-217
 
10) Silverberg DS, Wexler D, Iaina A : The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 2002 ; 4 : 681-686
 
11) Maeda M, Kanzaki H, Hasegawa T, et al : Arterial stiffening is a crucial factor for left ventricular diastolic dysfunction in a community-based normotensive population. Int J Cardiol Hypertens 2020 ; 6 : 100038
 
12) Okura H, Takada Y, Yamabe A, et al : Age- and Gender-Specific Changes in the Left Ventricular Relaxation : A Doppler Echocardiographic Study in Healthy Individuals. Circ Cardiovasc Imaging 2009 ; 2 : 41-46
 
13) Zhao Z, Wang H, Jessup JA, et al : Role of estrogen in diastolic dysfunction. Am J Physiol Heart Circ Physiol 2014 ; 306 : H628-H640
 
14) Suthahar N, Meijers WC, Ho JE, et al : Sex-specific assoiations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population. Eur J Heart Fail 2018 ; 20 : 1205-1214
 
15) Sarzani R, Dessi-Fulgheri P, Paci VM, et al : Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 1996 ; 19 : 581-585
 
16) Pasquali R : Obesity and androgens : facts and perspectives. Fertil Steril 2006 ; 85 : 1319-1340
 
17) 徳留健, 岸本一郎, 寒川賢治 : 循環器領域におけるナトリウム利尿ペプチドの病態生理学的意義. 循環器専門医 2016 ; 24 : 12-19
 
18) Wang TJ, Larson MG, Levy D, et al : Impact of Obesity on Plasma Natriuretic Peptide Levels. Circulation 2004 ; 109 : 594-600
 
P.1023 掲載の参考文献
1) Linssen GC, Bakker SJ, Voors AA, et al : N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. Eur Heart J 2010 ; 31 : 120-127
 
2) Luchner A, Behrens G, Stritzke J, et al : Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population : contribution of age, gender, and cardiac and extra-cardiac factors. Eur J Heart Fail 2013 ; 15 : 859-867
 
3) Jia X, Al Rifai M, Hoogeveen R, et al : Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol 2023 ; 8 : 222-230
 
4) 須川正宏 : 心血管検診における血漿BNP高値の関連因子と性差. 心臓 2023 ; 55 : 1015-1022
 
5) Wang TJ, Larson MG, Levy D, et al : Impact of obesity on plasma natriuretic peptide levels. Circulation 2004 ; 109 : 594-600
 
6) Bachmann KN, Huang S, Lee H, et al : Effect of Testosterone on Natriuretic Peptide Levels. J Am Coll Cardiol 2019 ; 73 : 1288-1296
 
7) Dai Z, Ohde S : Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in the Population Without Clinical Heart Failure. JAMA Cardiol 2023 Jul 12. doi : 10.1001/jamacardio.2023.1962 [Online ahead of print]
 
8) Dai Z, Asano T, Takahashi O, et al : The minimal informative monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure. BMC Cardiovasc Disord 2020 ; 20 : 262
 
9) Cheong AT, Tong SF, Chinna K, et al : Gender differences in factors influencing intention to undergo cardiovascular disease health checks : A cross-sectional survey. PLoS One 2020 ; 15 : e0239679
PubMed
P.1029 掲載の参考文献
1) Powell JT, Sweeting MJ, Ulug P, et al : Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years. Br J Surg 2017 ; 104 : 166-178
PubMed
2) Patel SR, Allen C, Grima MJ, et al : A Systematic Review of Predictors of Reintervention After EVAR : Guidance for Risk-Stratified Surveillance. Vasc Endovascular Surg 2017 ; 51 : 417-428
 
3) Bonvini S, Wassermann V, Menegolo M, et al : Surgical infrarenal "neo-neck" technique during elective conversion after EVAR with suprarenal fixation. Eur J Vasc Endovasc Surg 2015 ; 50 : 175-180
 
4) The Japanese Society for Vascular Surgery Database Management Committee Member, NCD Vascular Surgery Data Analysis Team : Vascular Surgery in Japan : 2016 Annual Report by the Japanese Society for Vascular Surgery. Ann Vasc Dis 2021 ; 14 : 419-438
 
5) Hoshina K, Ishimaru S, Sasabuchi Y, et al : Outcomes of Endovascular Repair for Abdominal Aortic Aneurysms : A Nationwide Survey in Japan. Ann Surg 2019 ; 269 : 564-573
 
6) White GH, May J : How should endotension be defined? History of a concept and evolution of a new term. J Endovasc Ther 2000 ; 7 : 435-438
 
7) Veith FJ, Baum RA, Ohki T, et al : Nature and significance of endoleaks and endotension : summary of opinions expressed at an international conference. J Vasc Surg 2002 ; 35 : 1029-1035
 
8) Torres-Blanco A, Miralles-Hernandez M : Endotension : twenty years of a controversial term. CVIR Endovasc 2021 ; 4 : 46
 
9) Kelso RL, Lyden SP, Butler B, et al : Late conversion of aortic stent grafts. J Vasc Surg 2009 ; 49 : 589-595
 
10) 百瀬匡亨, 大木隆生, 前田剛志, ほか : 腹部大動脈瘤に対するステントグラフト内挿術後に大動脈瘤-S状結腸瘻を発症した1例. 血管外科 2020 ; 39 : 51-58
 
11) 佐藤裕喜, 佐藤大樹, 中澤聡 : EVAR後の遠隔期エンドテンション経過観察中に破裂した腹部大動脈瘤の1例. 日臨外会誌 2018 ; 79 : 1403-1407
 
12) Habets J, Zandvoort HJ, Reitsma JB, et al : Magnetic resonance imaging is more sensitive than computed tomography angiography for the detection of endoleaks after endovascular abdominal aortic aneurysm repair : a systematic review. Eur J Vasc Endovasc Surg 2013 ; 45 : 340-350
 
13) Chastant R, Canaud L, Ozdemir BA, et al : Elective late open conversion after endovascular aneurysm repair is associated with comparable outcomes to primary open repair of abdominal aortic aneurysms. J Vasc Surg 2021 ; 73 : 502-509
 
14) Cerna M, Kocher M, Utikal P, Bachleda P : Endotension after endovascular treatment of abdominal aortic aneurysm : percutaneous treatment. J Vasc Surg 2009 ; 50 : 648-651
 
15) Kougias P, Lin PH, Dardik A, et al : Successful treatment of endotension and aneurysm sac enlargement with endovascular stent graft reinforcement. J Vasc Surg 2007 ; 46 : 124-127
 
16) Mennander A, Pimenoff G, Heikkinen M, et al : Nonoperative approach to endotension. J Vasc Surg 2005 ; 42 : 194-199
 
P.1034 掲載の参考文献
1) Gowda RM, Khan IA, Nair CK, et al : Cardiac papillary fibroelastoma : A comprehensive analysis of 725 cases. Am Heart J 2003 ; 146 : 404-410
 
2) Yanagawa B, Mazine A, Chan EY, et al : Surgery for tumors of the heart. Semin Thorac Cardiovasc Surg 2018 ; 30 : 385-397
 
3) Tamin SS, Maleszewski JJ, Scott CG, et al : Prognostic and Bioepidemiologic Implications of Papillary fibroelastomas. J Am Coll Cardiol 2015 ; 65 : 2420-2429
 
4) Zoltowska DM, Sadic E, Becoats K, et al : Cardic papillary fibroelastoma. J Geriatr Cardiol 2021 ; 18 : 346-351
 
5) Sun JP, Asher CR, Yang XS, et al : Clinical and echocardiographic characteristics of papillary fibroelastomas : a retrospective and prospective study in 162 patients. Circulation 2001 ; 103 : 2687-2693
 
6) Sorour AA, Kurmann RD, El-Am EA, et al : Recurrence of Pathologically Proven Papillary Fibroelastoma. Ann Thorac Surg 2022 ; 113 : 1208-1214
 
7) Mazur P, Kurmann R, Klarich KW, et al : Operative management of cardiac papillary fibroelastomas. J Thorac Cardiovasc Surg 2022 Jul 16 ; S0022-5223 (22) 00744-9. doi : 10.1016/j.jtcvs.2022.06.022 [Online ahead of print]
 
P.1040 掲載の参考文献
1) de Athayde Soares R, Matielo MF, Brochado Neto FC, et al : Analysis of the results of endovascular and open surgical treatment of acute limb ischemia. J Vasc Surg 2019 ; 69 : 843-849
 
2) Nishimoto Y, Toma M, Miyamoto R, et al : Successful Percutaneous Fogarty Arterial Thrombectomy for Acute Lower Limb Ischemia. JACC Cardiovasc Interv 2021 ; 14 : 706-708
 
3) Norgren L, Hiatt WR, Dormandy JA, et al ; TASC II Working Group : Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007 ; 45 Suppl S : S5-67
 
4) Rutherford RB, Baker JD, Ernst C, et al : Recommended standards for reports dealing with lower extremity ischemia : revised version. J Vasc Surg 1997 ; 26 : 517-538
 
5) Xiao X, Feng R, Wang M, et al : Comparisons of outcomes of open surgery versus endovascular intervention for thrombotic popliteal artery aneurysm with acute lower limb ischemia : a systematic review. BMC Surg 2022 ; 22 : 398
 
6) Yanagiuchi T, Kato T, Hanabusa K, et al : Successful Percutaneous Fogarty Thrombectomy for Subacute Lower Limb Ischemia Due to Resistant Thrombus in the Popliteal Artery. Am J Case Rep 2022 ; 23 : e936377
PubMed
7) Sieren MM, Pfarr J, Aludin S, et al : Percutaneous Thrombectomy in Patients with Occlusions of the Aortoiliac Segment : A Case Series. Cardiovasc Intervent Radiol 2022 ; 45 : 1684-1692
 
8) 安達健, 川口克廣, 小川恭弘, ほか : 急性下肢動脈閉塞症に対するガイドワイヤー併用Fogartyスルールーメンカテーテルの治療効果-従来型Fogartyカテーテルとの比較-. 心臓 2019 ; 51 : 684-689
 
9) Blaisdell FW : The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome : a review. Cardiovasc Surg 2002 ; 10 : 620-630
 

書評

最近チェックした商品履歴

Loading...